Ana Peiro
Doctor of Medicine, specialist in Clinical Pharmacology (2002), she is a Full Professor (2019) at the Miguel Hernández University (UMH), where she has taught as an associate since 2003, in subjects related to Pharmacology in Medicine, Pharmacy and Podiatry. In addition, she has a degree in "Social and Cultural Anthropology", a Diploma and Master's degree in "Research Methodology: Design and Statistics in Health Sciences" (UAB) and a master's degree in "Bioethics" (EVES). She has participated as a teacher in doctoral and postgraduate programs, uninterruptedly since 2022 (UMH). Her CV highlights the continuity of her research on interindividual variability in pharmacological response, which since her stay at UCSD (US, 2006) has focused on the polymedicated population with chronic pain and functional diversity, being an attending physician in the Pain Unit since 2012. In these pathologies, she investigates pharmacogenetic markers and sex/gender interaction as explanatory variables of said variability. With this dual objective, she received a grant for Independent Clinical Research Projects (ISCII, 2020) with the title "Gender biases in pain medicine: from omics to health care". She coordinates the “Platform for Applied Pharmacogenetics for Research” (ISABIAL Foundation), the “Recommendation in Pharmacogenetics” Working Group of the Spanish Society of Pharmacogenetics and Pharmacognomics (SEFF) and the multidisciplinary research group “Neuropharmacology applied to Pain and Functional Diversity” from the ISABIAL Foundation. Previously, she has participated as a collaborator or principal in more than 90 research projects / clinical trials (40 with competitive grants, 24 independent sponsors and 30 from the industry), directed 6 doctoral theses (plus 6 in progress) and nearly 30 final master's / degree projects. She is an active scientific communicator, with nearly 200 posters/communications at scientific conferences and in more than 70 events in various social forums (Pint of Science, Women and Girls in Science Day, European Night of Science, TEDxValencia: women's lounge, among others) individually and collectively, as a member of the group of scientific communicators "BigVanCiencia" and "Scientists and Artists" (FISABIO Foundation). Her work has earned her several awards (Outstanding UMH Teacher 2004, Fundación Hospital Optimista 2017, Royal National Academy of Pharmacy 2017, Famelab-FECYT scientific monologues 2017, Extraordinary Pain Award, Grünenthal Foundation 2018, Awards for the best Doctoral Theses in the field of pain from the Spanish Pain Society 2018, 2019, and Hestia Award for care for functional diversity 2020, Best Research Project Award, SEFF 2022).
LIST OF MOST RELEVANT CONTRIBUTIONS
Most important publications in books and journals with “peer review” and conferences
AC: Corresponding author; (nº x / nº y): position of applicant signature / total authors. If applicable, indicate the number of citations
Scientific article. Marie Gombert; Pura Ballester; Ana Segura; (AC). (4/ 4). 2021. Introducing sexual dysfunction in mental care Expert Opin Drug Saf. 20-1, pp.69-79. WOS (0) https://doi.org/10.1080/14740338.2020.1849135
Scientific article. Mª Angeles Pena Pardo; Javier Muriel; Miram Saiz-Rodriguez; Alberto Borobia; Francisco Abad-Santos; Jesus Frias; (AC). (7/7). 2020. Effect of cytochrome P450 and ABCB1 polymorphisms on Imatinib pharmacokinetics after single-dose administration to healthy subjects Clin Drug Investig. 40-7, pp.617-628. WOS (2) https://doi.org/10.1007/s40261-020-00921-7
Scientific article. Pure Ballester; Amanda Richdale; Emma Baker; Ana Maria Peiro Peiro. (4/4). 2020. Sleep in autism: A biomolecular approach to aetiology and treatment Sleep Med Rev. 54-101357. WOS (8) https://doi.org/10.1016/j.smrv.2020.101357
Scientific article. To Montes; G Rock; JC Statistics; S Sabate; Ana Mª Peiro. (21/96). 2020. Presurgical risk model for chronic postsurgical pain based on six clinical predictors: a prospective external validation Pain. 161-11, pp.2611-2618. WOS (7) https://doi.org/10.1097/j.pain.0000000000001945
Scientific article. Ana Peiro; Health Gutiérrez; Beatriz Planelles; Teresa Femenía; Carlos Mingote; Jorge Manzanares. (1/6). 2020. Association of Cannabinoid Receptor Genes ( CNR1 and CNR2) Polymorphisms and Panic Disorder Anxiety Stress Coping. 33-3, pp.256-265. WOS (5) https://doi.org/10.1080/10615806.2020.1732358
Scientific article. Beatriz Planelles; Caesar Margaret María Mar Inda; et al; (AC). (9/9). 2019. Gender based differences, pharmacogenetics and adverse events in chronic pain management.Pharmacogenomics J.WOS (9) https://doi.org/10.1038/s41397-019-0118-9
Scientific article. Pure Ballester; M José Martínez; M of the Inda Sea; et al;. (11/11). 2019. Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.J Psychopharmacol.33-11, pp.1395-1406. WOS (5) https://doi.org/10.1177/0269881119864968
Scientific article. Javier Muriel; Caesar Margaret Jordi Barrachina; et al; (AC). (9/9). 2019. Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients Basic Clin Pharmacol Toxicol.124-4, pp.439-448. WOS (8) https://doi.org/10.1111/bcpt.13155.
Scientific article. Caesar Margaret Pure Ballester; M of the Inda Sea; et al; (AC). (9/9). 2019. OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids.Pain Physician.22-1, pp.97-107. WOS (9)
Scientific article. Pure Ballester; M José Martínez; Auxi Javaloyes; et al;. 2019. Sleep problems in adults with autism spectrum disorder and intellectual disability.Autism Res.12-1, pp.66-79. WOS (33) https://doi.org/10.1002/aur.2000